{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:47:12Z","timestamp":1746337632514},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1053\/j.jrn.2010.04.005","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T08:51:01Z","timestamp":1279788661000},"page":"246-256","source":"Crossref","is-referenced-by-count":8,"title":["Association Between Adherence to Folic Acid Supplements and Serum Folate, and Plasma Homocysteine Among Hemodialysis Patients"],"prefix":"10.1053","volume":"21","author":[{"given":"June","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Hibberd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2010.04.005_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000057473","article-title":"Vitamin replacement therapy in renal failure patients","volume":"25","author":"Makoff","year":"1999","journal-title":"Miner Electrolyte Metab"},{"key":"10.1053\/j.jrn.2010.04.005_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/088453369901400505","article-title":"Renal failure and the concomitant derangement of micronutrient metabolism","volume":"14","author":"Makoff","year":"1999","journal-title":"Nutr Clin Pract"},{"key":"10.1053\/j.jrn.2010.04.005_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ki.1993.185","article-title":"Water soluble vitamins in chronic hemodialysis patients and need for supplementation","volume":"43","author":"Descombes","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.04.005_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000169398","article-title":"Vitamin levels in chronic renal failure and need for supplementation","volume":"3","author":"Stein","year":"1985","journal-title":"Blood Purif"},{"key":"10.1053\/j.jrn.2010.04.005_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-6386(98)70145-3","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here?","volume":"32","author":"Levey","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"10.1053\/j.jrn.2010.04.005_bib6","first-page":"S1","article-title":"National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K\/DOQI) Advisory Board: K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.04.005_bib7","first-page":"669","article-title":"Hyperhomocysteinemia and the prevalence of atherosclerotic vascular disease in patients with end stage renal disease","volume":"32","author":"Manns","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 4","key":"10.1053\/j.jrn.2010.04.005_bib8","doi-asserted-by":"crossref","first-page":"S1258","DOI":"10.1093\/jn\/126.suppl_4.1258S","article-title":"Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population","volume":"126","author":"Selhub","year":"1996","journal-title":"J Nutr"},{"key":"10.1053\/j.jrn.2010.04.005_bib9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2010.04.005_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.274.13.1049","article-title":"Quantitative assessment of plasma homocysteine as a risk factor for vascular disease","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1053\/j.jrn.2010.04.005_bib11","first-page":"S72","article-title":"Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients","volume":"41","author":"Chauveau","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.04.005_bib12","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2010.04.005_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence","volume":"131","author":"Eikelboom","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2010.04.005_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/j.jrn.2010.04.005_bib15","first-page":"279","article-title":"Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease","volume":"2","author":"Kang","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"10.1053\/j.jrn.2010.04.005_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/089686080002000202","article-title":"Homocysteine, vitamin B12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients","volume":"20","author":"De Vecchi","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.jrn.2010.04.005_bib17","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.ATV.17.11.2554","article-title":"Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: a prospective study","volume":"17","author":"Bostom","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.jrn.2010.04.005_bib18","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1681\/ASN.V12102181","article-title":"The kidney and homocysteine metabolism","volume":"12","author":"Friedman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2010.04.005_bib19","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1046\/j.1523-1755.1999.00378.x","article-title":"Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis","volume":"55","author":"Moustapha","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.04.005_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1051-2276(01)31274-8","article-title":"Homocysteine lowering effect of different multi-vitamin preparations in patients with end-stage renal disease","volume":"11","author":"Dierkes","year":"2001","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2010.04.005_bib21","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.101.24.2829","article-title":"Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients","volume":"101","author":"Bostom","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2010.04.005_bib22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","article-title":"Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease","volume":"15","author":"Wrone","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2010.04.005_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000093680","article-title":"Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients","volume":"24","author":"Righetti","year":"2006","journal-title":"Blood Purif"},{"key":"10.1053\/j.jrn.2010.04.005_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","article-title":"Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial","volume":"47","author":"Zoungas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jrn.2010.04.005_bib25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end stage renal disease","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2369-9-2","article-title":"A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease","volume":"9","author":"Karamanidou","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.jrn.2010.04.005_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/2047-783X-14-5-185","article-title":"Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature","volume":"14","author":"Schmid","year":"2009","journal-title":"Eur J Med Res"},{"key":"10.1053\/j.jrn.2010.04.005_bib28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1525-1594.2000.06553.x","article-title":"Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation","volume":"24","author":"Descombes","year":"2000","journal-title":"Artif Organs"},{"key":"10.1053\/j.jrn.2010.04.005_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0272-6386(99)70279-9","article-title":"Factors causing malnutrition in patients with chronic uremia","volume":"33","author":"Mitch","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.04.005_bib30","first-page":"95","article-title":"Renal DETERMINE nutrition screening tools for the identification and treatment of malnutrition","volume":"8","author":"Leung","year":"1998","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1053\/j.jrn.2010.04.005_bib31","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J\u00a0Med"},{"key":"10.1053\/j.jrn.2010.04.005_bib32","first-page":"8781","article-title":"United States Food and Drug Administration: Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid","volume":"61","year":"1996","journal-title":"Fed Regist"},{"key":"10.1053\/j.jrn.2010.04.005_bib33","unstructured":"United States Department of Agriculture, Agriculture Research Service: USDA National Nutrient Database for Standard Reference, Release 21. 2008. Available at: http:\/\/www.ars.usda.gov\/ba\/bhnrc\/ndl. Accessed November 2008 [retrieved from Nutrient Data Laboratory Home Page]"},{"key":"10.1053\/j.jrn.2010.04.005_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","article-title":"Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection","volume":"422","author":"Araki","year":"1987","journal-title":"J Chromatogr"},{"key":"10.1053\/j.jrn.2010.04.005_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02263621","article-title":"A new enzymatic method for pyridoxal-5'-phosphate determination","volume":"4","author":"Shin-Buehring","year":"1981","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.jrn.2010.04.005_bib36","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.00954.x","article-title":"Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial","volume":"60","author":"Miskulin","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.04.005_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1377\/hlthaff.27.1.89","article-title":"Out-of-pocket spending and medication adherence among dialysis patients in twelve countries","volume":"27","author":"Hirth","year":"2008","journal-title":"Health Aff"},{"key":"10.1053\/j.jrn.2010.04.005_bib38","first-page":"162","article-title":"Why all prescribed medications are not taken: results from a survey of chronic dialysis patients","volume":"22","author":"Holley","year":"2006","journal-title":"Adv Perit Dial"},{"key":"10.1053\/j.jrn.2010.04.005_bib39","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2010.04.005_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jcp.56.12.924","article-title":"Red cell or serum folate? Results from the National Pathology Alliance benchmarking review","volume":"56","author":"Galloway","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.jrn.2010.04.005_bib41","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/aje\/kwg039","article-title":"Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study","volume":"157","author":"Satia-Abouta","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"Suppl 1","key":"10.1053\/j.jrn.2010.04.005_bib42","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1093\/ajcn\/59.1.232S","article-title":"Collection of dietary-supplement data and implications for analysis","volume":"59","author":"Block","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2010.04.005_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/aje\/148.7.643","article-title":"Validity of methods used to assess vitamin and mineral supplement use","volume":"148","author":"Patterson","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.jrn.2010.04.005_bib44","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/ajcn\/59.4.940","article-title":"Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease","volume":"59","author":"Pancharuniti","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2010.04.005_bib45","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/01.STR.26.7.1166","article-title":"Serum folate and risk for ischemic stroke. First National Health and Nutrition Examination Survey epidemiologic follow-up study","volume":"26","author":"Giles","year":"1995","journal-title":"Stroke"},{"key":"10.1053\/j.jrn.2010.04.005_bib46","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1001\/jama.275.24.1893","article-title":"Serum folate and risk of fatal coronary heart disease","volume":"275","author":"Morrison","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.97.5.437","article-title":"Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease","volume":"97","author":"Robinson","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2010.04.005_bib48","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.277.22.1775","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jama.279.5.359","article-title":"Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women","volume":"279","author":"Rimm","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib51","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib52","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2010.04.005_bib53","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2010.04.005_bib54","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.04.005_bib56","first-page":"A3642","article-title":"Blinded comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial","volume":"19","author":"Baker","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2010.04.005_bib57","unstructured":"Leung J, Dwyer J, Hibberd P, et al: Folic acid supplementation and cardiac and stroke mortality among hemodialysis patients. J Ren Nutr (in press)"},{"key":"10.1053\/j.jrn.2010.04.005_bib58","first-page":"195","article-title":"A pilot study with simvastatin and folic acid\/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)","volume":"10","author":"MacMahon","year":"2000","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1053\/j.jrn.2010.04.005_bib59","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000047761","article-title":"The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke","volume":"13","year":"2002","journal-title":"Cerebrovasc Dis"},{"key":"10.1053\/j.jrn.2010.04.005_bib60","first-page":"428","volume":"7","author":"Galan","year":"2003","journal-title":"J Nutr Health Aging"},{"key":"10.1053\/j.jrn.2010.04.005_bib61","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.ahj.2006.03.004","article-title":"Rationale and design of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial","volume":"152","author":"Bostom","year":"2006","journal-title":"Am Heart J"},{"key":"10.1053\/j.jrn.2010.04.005_bib62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ahj.2005.04.025","article-title":"Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials","volume":"151","year":"2006","journal-title":"Am Heart J"},{"key":"10.1053\/j.jrn.2010.04.005_bib63","series-title":"National Academy of Sciences, Institute of Medicine, Food and Nutrition Board: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline","year":"1998"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227610001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227610001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T01:40:22Z","timestamp":1635730822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227610001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1051227610001081"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2010.04.005","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}